
Agilent Technologies Inc
NYSE:A

Relative Value
The Relative Value of one
A
stock under the Base Case scenario is
170.97
USD.
Compared to the current market price of 115.67 USD,
Agilent Technologies Inc
is
Undervalued by 32%.
Relative valuation is one of two methods of placing a monetary value on a company; the other is Discounted Cash Flow valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.

Valuation Multiples
Multiples Across Competitors
A Competitors Multiples
Agilent Technologies Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
34.1B USD | 4.8 | 25.3 | 18 | 21.1 | |
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
196B USD | 4.5 | 32.6 | 20.6 | 30.1 | |
US |
![]() |
Danaher Corp
NYSE:DHR
|
167B USD | 5.4 | 24.5 | 16.9 | 21.5 | |
CH |
![]() |
Lonza Group AG
SIX:LONN
|
42.5B CHF | 6.8 | 35 | 27.2 | 27.2 | |
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
56.1T KRW | 17.5 | 70.7 | 40.2 | 54.9 | |
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
36.5B USD | 2.5 | 34.6 | 15.9 | 25.8 | |
US |
![]() |
Illumina Inc
NASDAQ:ILMN
|
31.1B USD | 7 | -6.9 | 60 | 290.1 | |
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
29.1B USD | 7.4 | 32.8 | 24.4 | 26.8 | |
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
199B CNY | 5 | 22.5 | 20.8 | 20.8 | |
US |
![]() |
West Pharmaceutical Services Inc
NYSE:WST
|
24.8B USD | 8.6 | 45 | 28.2 | 33 | |
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
23.2B EUR | 6.9 | 32.2 | 22.4 | 27.2 |
P/S Multiple | Revenue Growth | |||
---|---|---|---|---|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
4.8
|
20%
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
4.5
|
19%
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
5.4
|
12%
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
6.8
|
39%
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
17.5
|
47%
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
2.5
|
27%
|
US |
![]() |
Illumina Inc
NASDAQ:ILMN
|
7
|
44%
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
7.4
|
18%
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
5
|
135%
|
US |
![]() |
West Pharmaceutical Services Inc
NYSE:WST
|
8.6
|
20%
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
6.9
|
30%
|
P/E Multiple | Earnings Growth | |||
---|---|---|---|---|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
25.3
|
69%
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
32.6
|
72%
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
24.5
|
29%
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
35
|
45%
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
70.7
|
35%
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
34.6
|
137%
|
US |
![]() |
Illumina Inc
NASDAQ:ILMN
|
Negative Multiple: -6.9 | N/A |
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
32.8
|
38%
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
22.5
|
145%
|
US |
![]() |
West Pharmaceutical Services Inc
NYSE:WST
|
45
|
21%
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
32.2
|
19%
|
EV/EBITDA Multiple | EBITDA Growth | |||
---|---|---|---|---|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
18
|
32%
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
20.6
|
23%
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
16.9
|
6%
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
27.2
|
91%
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
40.2
|
46%
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
15.9
|
52%
|
US |
![]() |
Illumina Inc
NASDAQ:ILMN
|
60
|
68%
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
24.4
|
25%
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
20.8
|
261%
|
US |
![]() |
West Pharmaceutical Services Inc
NYSE:WST
|
28.2
|
23%
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
22.4
|
34%
|
EV/EBIT Multiple | EBIT Growth | |||
---|---|---|---|---|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
21.1
|
62%
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
30.1
|
56%
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
21.5
|
18%
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
27.2
|
37%
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
54.9
|
50%
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
25.8
|
100%
|
US |
![]() |
Illumina Inc
NASDAQ:ILMN
|
290.1
|
186%
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
26.8
|
32%
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
20.8
|
195%
|
US |
![]() |
West Pharmaceutical Services Inc
NYSE:WST
|
33
|
22%
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
27.2
|
37%
|